Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Peptron Inc. currently has 1 pending office action within its patent portfolio. This action is being reviewed by 1 distinct examiner, which limits the scope of active prosecution the company must manage. This concentration allows for a focused response strategy for the pending matter currently at the office.
The busiest examiner for the company is EDGINGTONGIORDANO, FRANCESCA, who is handling the busiest examiner pending office action. This action constitutes the entirety of the company's current pending workload, reflecting a specific point of engagement. The involvement of a distinct examiner suggests a simplified administrative process for the company's active filings, as there are no competing examiner styles to address.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EDGINGTONGIORDANO, FRANCESCA | 1 | 70.8% | +31.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18686834 | NOVEL ANTI-MUC1 ANTIBODY AND USE THEREOF | EDGINGTONGIORDANO, FRANCESCA | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18686834 | NOVEL ANTI-MUC1 ANTIBODY AND USE THEREOF | EDGINGTONGIORDANO, FRANCESCA | — | §102§112DP | Non-Final OA | — | Pending | Feb 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial